Enlargement rate of geographic atrophy before and after secondary CNV conversion with associated anti-VEGF treatment.
Jakob SiedleckiCaroline KochBenedikt SchwormRaffael LieglThomas KreutzerKarsten U KortuemRicarda SchumannSiegfried G PriglingerArmin WolfPublished in: BMC ophthalmology (2021)
In this pilot study, primary GA enlargement did not seem to be influenced by a secondary CNV. No association between the intensity of anti-VEGF treatment and changes in atrophy enlargement rates were found. Further studies with larger sample sizes are warranted.